Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-695 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-6615 |
filingDate |
2009-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2011-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dbfa3bdc7203ab83eb76d38fe9d463b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7055d18fb82102223daeb850cc69ff6f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6008abd2be54aa19d54068d8087fe389 |
publicationDate |
2011-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7989433-B2 |
titleOfInvention |
Substituted thieno[3,2-D]pyrimidines as melanin concentrating hormone receptor-1 antagonists |
abstract |
The present invention provides compounds having the following Formula IA and IB, which are useful as MCHR1 antagonists, and includes prodrugs and pharmaceutically acceptable salts thereof: |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018000085-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9655900-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9388195-B2 |
priorityDate |
2008-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |